CIDRAP newsletters options
Yet 80% of low-risk newborns got antibiotics, and for similar durations as high-risk infants.
Danish microbiome technology company SNIPR Biome ApS announced this week that the US Food and Drug Administration has approved the company's application to initiate the first human clinical trial of its CRISPR-based drug for preventing Escherichia coli infections in cancer patients.
Austrian scientists writing in a letter in the New England Journal of Medicine yesterday demonstrate poor neutralization of the Omicron variant when using serum from vaccinated or recovered COVID-19 patients, potentially signaling a need for variant-specific vaccines.
The steps are part of continued efforts to keep schools open for in-person learning.
Risk factors were older age, chronic conditions, and longer symptoms.
"Almost 50,000 deaths a week is 50,000 deaths too many," says WHO head.
The US COVID-19 vaccination program may have averted 14 million infections, saved more than 240,000 lives, and prevented upwards of 1.1 million hospitalizations in the first half of 2021, according to estimates from a modeling study yesterday in JAMA Network Open.
A study of 42 million US patient visits for antibiotic-inappropriate acute respiratory infections (ARIs) found that more than 10% received an antibiotic prescription, with providers in urgent care clinics and southern states among the most likely prescribers, US researchers reported this week in Infection Control & Hospital Epidemiology.
Yesterday the US reported 1.35 million new COVID-19 cases, the most any nation has ever reported in 1 day.
New data show the Omicron variant spreads more easily by asymptomatic people.
Those who got a third dose had 12.8 cases per 100,000 person-days, vs 116 in the unboosted.
A new review of the antibiotic development pipeline finds that there are relatively few clinically differentiated products in late-stage clinical development, especially against critical, multidrug-resistant pathogens, an international team of researchers reported yesterday in Antimicrobial Agents and Chemotherapy.
US Federally qualified health centers (FQHCs) have been critical to providing COVID-19 vaccinations to low-income and racial minority populations, finds a study yesterday in JAMA Network Open.
A key MRSA strain appears to predate, by more than 100 years, the advent of the antibiotic era.
As hospital bed occupancy nears record levels, a quarter of US hospitals report critical staffing shortages.
The vaccine was 91% protective against MIS-C, a rare inflammatory disorder.
T cells induced by infection with coronaviruses such as those that cause the common cold might help protect against COVID-19, finds a small UK study today in Nature Communications.
In another study, researchers found a third vaccine dose boosts immune response in cancer patients.
Only 15% of younger children are vaccinated, compared with more than half of adolescents.
Countries took new steps to slow the spread, and new UK data show boosters provide strong protection against severe Omicron infection.
